Electromed (ELMD) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Electromed | 300.53 Mn | 283.55 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.20% |
| Dec 31, 2025 | -60.29% |
| Sep 30, 2025 | -26.63% |
| Jun 30, 2025 | -4.39% |
| Mar 31, 2025 | 24.37% |
| Dec 31, 2024 | 3.64% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | 47.43% |
| Mar 31, 2024 | -7.56% |
| Dec 31, 2023 | 6.06% |
| Sep 30, 2023 | -32.79% |
| Jun 30, 2023 | -21.78% |
| Mar 31, 2023 | -26.99% |
| Dec 31, 2022 | -27.70% |
| Sep 30, 2022 | -20.10% |
| Jun 30, 2022 | -17.94% |
| Mar 31, 2022 | -22.76% |
| Dec 31, 2021 | -5.19% |
| Sep 30, 2021 | -30.64% |
| Jun 30, 2021 | 4.04% |
| Mar 31, 2021 | 5.62% |
| Dec 31, 2020 | 5.95% |
| Sep 30, 2020 | 6.51% |
| Jun 30, 2020 | 12.35% |
| Mar 31, 2020 | -28.45% |
| Dec 31, 2019 | -10.80% |
| Sep 30, 2019 | -20.14% |
| Jun 30, 2019 | -30.24% |
| Mar 31, 2019 | 23.46% |
| Dec 31, 2018 | 3.80% |
| Sep 30, 2018 | 26.38% |
| Jun 30, 2018 | 11.92% |
| Mar 31, 2018 | 6.19% |
| Dec 31, 2017 | 13.85% |
| Sep 30, 2017 | 14.49% |
| Jun 30, 2017 | -18.14% |
| Mar 31, 2017 | -7.80% |
| Dec 31, 2016 | 9.87% |
| Sep 30, 2016 | 21.44% |
| Jun 30, 2016 | -15.00% |
| Mar 31, 2016 | 4.43% |
| Dec 31, 2015 | 31.61% |
| Sep 30, 2015 | 17.13% |